Wenhao Ma

发表

ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1

P. Gao, Yi Zhang, Huafeng Zhang, 2020, Nature Cancer.

DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing.

Zhaoyong Li, P. Gao, Huafeng Zhang, 2019, Cancer research.

HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer.

Fan Luo, Li Zhang, Hongyun Zhao, 2022, Cancer letters.

Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps

Huafeng Zhang, Xiuying Zhong, Yongping Cai, 2023, Nature Communications.

Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1

G. Semenza, P. Gao, Huafeng Zhang, 2021, Cancer Research.

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

K. Qu, Pengfei Cai, Huafeng Zhang, 2022, Protein & Cell.

KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression

P. Gao, Huafeng Zhang, Xiuying Zhong, 2021, Cancer communications.

Ultrasensitive detection of microRNA-21 by using specific interaction of antimonene with RNA as electrochemical biosensor.

D. Huo, Mei Yang, Changjun Hou, 2021, Bioelectrochemistry.

ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism

Jie Cao, Huafeng Zhang, Linchong Sun, 2023, Nature Chemical Biology.